Loading...

By MBN Staff - Tue, 03/05/2024 - 13:20

UCB invests in IMIDomics to advance treatments for inflammatory diseases, reflecting a commitment to medical innovation.

Featured content

Thu, 04/11/2024 - 15:25

Current regulation in Mexico hinders the full development of healthcare markets, including cannabis and AI, says BPF’s Jaime Castro.

https://mexicobusiness.news/tag/ucb

More Health

By Miriam Bello - Thu, 02/11/2021 - 09:00

Moving the focus of healthcare from sickness treatment to sustained health demands disruption and structural change.

By Miriam Bello - Tue, 08/04/2020 - 11:29

A global pandemic has demonstrated that we can all be a support for other. Here is how to take care of mental health for you and those around you.

By Miriam Bello - Tue, 07/14/2020 - 16:21

MBN interviewees share their vision on how to take advantage of technology to improve healthcare services and ensure accessibility.

By Miriam Bello - Tue, 07/14/2020 - 09:13

Omar Lugo says the key behind UCB’s innovation and growth has been listening to the patient.

By Miriam Bello - Fri, 07/03/2020 - 14:06

Pharmaceutical industry leaders share their views on the “payment by results” method to increase healthcare access.

By - Wed, 09/05/2018 - 13:58

UCB is a biopharmaceutical company that has specialized in serious diseases since 1928, mainly in two therapeutic areas: neurology and immunology.